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INTRODUCTION
Toll-like receptors (TLRs) are mammalian homologues of
Toll, which was originally identified in Drosophila (1). These
receptors are expressed on both immune as well as non-
immune cells and respond to specific components of micro-
bial pathogens. TLR signaling results in the activation of
nuclear factor  B (NF- B), which triggers the production
of a variety of antimicrobial and proinflammatory cytokines
and chemokines (1, 2).
At least ten different human TLRs have been identified and
have variable expression in different cell types as well as dif-
ferential responses to a wide range of pathogens (3-5). For
instance, TLR2 mediates responses to gram-positive bacte-
ria-derived peptidoglycan, lipoprotein, and zymosan, whereas
TLR4 mediates cellular responses to lipopolysaccharide derived
from gram-negative bacteria (4, 5). Likewise, TLR2 and 4
can be activated by certain viral envelope proteins (6), TLR3
by double-stranded viral RNA (7), TLR7 by imidazoquin-
lones (8), and TLR9 by unmethylated CpG DNA derived
from bacterial and viral genomes (9).
TLRs are expressed not only in peripheral blood mononu-
clear cells such as monocytes and macrophages (2, 3, 10), but
also in various tissue cells such as fibroblasts (11) and endothe-
lial cells (12). Our laboratory and other groups have reported
that human keratinocytes express TLR2 and 4 (13, 14). Pre-
vious immunohistochemical studies indicated that TLR2 ap-
pears to be primarily expressed in the granular layer of the
epidermis, while TLR4 is expressed principally in the basal
epidermal region (15, 16). Epidermal keratinocytes in normal
skin (NS) also constitutively expressed TLR1 and 5, while
TLR3 was barely detectable in most cases (16). However, no
studies have, to date, been carried out on the cutaneous expres-
sion patterns of TLRs in viral skin diseases.
In this study, we compared the expression of TLR2, 3, 4,
7, and 9 in the epidermis of normal human skin to that in
verruca vulgaris (VV) and molluscum contagiosum (MC)
skin lesions. The modulation of cutaneous proinflammatory
cytokines was also examined in NS, VV, and MC skin lesions.
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Expression of Toll-Like Receptors in Verruca and Molluscum
Contagiosum
Recent studies indicate that several Toll-like receptors (TLRs) are implicated in
recognizing viral structures and instigating immune responses against viral infec-
tions. The aim of this study is to examine the expression of TLRs and proinflamma-
tory cytokines in viral skin diseases such as verruca vulgaris (VV) and molluscum
contagiosum (MC). Reverse transcription-polymerase chain reaction and immunos-
taining of skin samples were performed to determine the expression of specific
antiviral and proinflammatory cytokines as well as 5 TLRs (TLR2, 3, 4, 7, and 9).
In normal human skin, TLR2, 4, and 7 mRNA was constitutively expressed, whereas
little TLR3 and 9 mRNA was detected. Compared to normal skin (NS), TLR3 and
9 mRNA was clearly expressed in VV and MC specimens. Likewise, immunohis-
tochemistry indicated that keratinocytes in NS constitutively expressed TLR2, 4,
and 7; however, TLR3 was rarely detected and TLR9 was only weakly expressed,
whereas 5 TLRs were all strongly expressed on the epidermal keratinocytes of VV
and MC lesions. In addition, the mRNA expression of IFN- and TNF- was upregu-
lated in the VV and MC samples. Immunohistochemistry indicated that IFN- and
TNF- were predominately localized in the granular layer in the VV lesions and adja-
cent to the MC bodies. Our results indicated that VV and MC skin lesions expressed
TLR3 and 9 in addition to IFN- and TNF- . These viral-induced proinflammatory
cytokines may play a pivotal role in cutaneous innate immune responses.
Key Words : Antiviral and Proinflammatory Cytokines; Molluscum Contagiosum; Toll-Like Receptors; Verruca
Vulgaris
Received : 27 February 2007
Accepted : 13 August 2007MATERIALS AND METHODS
Patients and tissue samples
Ten patients with VV, including 8 patients with VV and
2 patients with condyloma acuminatum, and 8 patients with
MC were enrolled in this study. Three-millimeter punch biop-
sies were taken from the skin lesions of each patient. In one
half portion of the biopsy specimen the epidermis was sepa-
rated from the dermis using a scalpel and was snap-frozen in
liquid nitrogen for reverse transcription polymerase chain reac-
tion (RT-PCR) studies. The other half of the specimen was
embedded in optimal cutting temperature (OCT) compound
(Sakura, Tokyo, Japan) for immunostaining. Five normal
human skin samples were obtained from the adjacent NS
tissue of patients who underwent benign cutaneous tumor
surgery. All the skin samples were stored at -70℃until fur-
ther use. Informed consent was obtained from all the patients
prior to collection of the samples.
RT-PCR
Each skin sample was homogenized in a polytron (Kinemat-
ica AG, Luzernerstrasse, Littau-Lucerne, Switzerland). The
total mRNA was isolated using TRIZOL
� reagent (Sigma,
Saint Louis, MO, U.S.A.) according to the manufacturer’s
instructions (17). cDNA was synthesized by performing
reverse transcription using 3  g of total mRNA from skin
samples with Avian Myeloblastosis Virus Reverse Transcrip-
tase (Promega Corporation, Madison, WI, U.S.A.) and ran-
dom primers at 42℃ for 90 min. RT-PCR was performed
as described in the manufacturer’s protocol. Briefly, initial
denaturation was performed at 94℃ for 5 min, followed by
35 amplification cycles of denaturing at 94℃ for 30 sec,
annealing for 30 sec (the temperatures are listed in Table 1),
extending at 72℃for 40 sec, and finally incubating at 72℃
for 10 min. Specific oligonucleotide primers used to ampli-
fy TLRs, tumor necrosis factor- (TNF- ), and interferon-
(IFN- ) were based on the published sequences (Table 1).
The PCR amplified products were analyzed by 1.5% agarose
gel electrophoresis and visualized by ethidium bromide stain-
ing with ultraviolet illumination. The quantifications of the
PCR products were normalized by comparison with the
amplified  -actin PCR product. The comparative mRNA
levels of different gene products in the viral infected skin
samples were designated as fold increases compared to the
normal human skin.
Immunohistochemical staining
Skin specimens were prepared for immunohistochemical
staining as previously described (18). Briefly, five-micron
cryostat sections were cut on a cryostat microtome (Leica
Microsystems AG, Wetzlar, Germany) and then fixed in ace-
tone for 15 min. After three washes in phosphate buffered saline
(PBS), the sections were incubated in methanol with 0.3%
hydrogen peroxide for 10 min to block the endogenous per-
oxidase activity. Nonspecific antibody binding was blocked
by incubating the sections with 10% normal donkey serum
(Jackson ImmunoResearch Laboratories, West Grove, PA,
U.S.A.) for 60 min. The sections were incubated with rabbit
anti-human polyclonal antibodies of TLR2 and 4, IFN- , and
TNF- (1:100 in phosphate-buffered saline [PBS], Santa Cruz
Biotechnology, Santa Cruz, CA, U.S.A.) or with goat anti-
human polyclonal antibodies of TLR3, 7, and 9 (1:100 in
PBS, Santa Cruz Biotechnology) overnight at 4℃. Subse-
quently, tissue sections were incubated with secondary anti-
bodies (1:300 in PBS, Jackson ImmunoResearch Laboratories)
for 60 min. As controls, the same skin specimens were incubat-
ed with an isotype-matched antibody using identical experi-
mental conditions. As a negative control, skin samples were
incubated with PBS without primary antibodies. The color
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Primer Sequences Size (bp) Annealing temperature (℃) References
TLR2 5′ -TGTGAACCTCCAGGCTCTG-3′ , 256 64 15
5′ -GTCCATATTTCCCACTCTCAGG-3′
TLR3 5′ -AGCCGCCAACTTCACAAG-3′ , 327 64 15
5′ -AGCTCTTGGAGATTTTCCAGC-3′
TLR4 5′ -ACAGAAGCTGGTGGCTGTG-3′ , 291 57 15
5′ -TCTTTAAATGCACCTGGTTGG-3′
TLR7 5′ -TTGGCTTCTGCTCAAATGC-3′ , 300 65 15
5′ -CTAAAGGTTGGAATTCACTGCC-3′
TLR9 5′ -GTGCCCCACTTCTCCATG-3′ , 260 62 15
5′ -GGCACAGTCATGATGTTGTTG-3′
IFN- 5′ -TCTAGCACTGGCTGGAATGAG-3′ , 276 55 17
5′ -CTTACAGGTTACCTCCGAAAC-3′
TNF- 5′ -GGGACCTCTCTCTAATCAGCCCTCTGG-3′ , 287 55 18
5′ -CCATCAGCCGCATCGCCGTC-3'
-actin 5′ -TCTACAATGAGCTGCGTGTG-3′ , 314 59 18
5′ -GGTGAGGATCTTCATGAGGT-3′
Table 1. Oligonucleotide primers used for reverse transcription-polymerase chain reaction reaction of treated tissue was carried out using the substrate
3-amino-9-ethylcarbazole (Vector Laboratories, Burlingame,
CA, U.S.A.) for 10 min. The skin sections were also counter-
stained with hematoxylin (Vector Laboratories) for 1 to 2
min. Three observers independently reviewed the stained
cells under a light microscope. The staining intensity was
graded as 0 for negative, + for weakly positive, ++ for mod-
erately positive, and +++ for strongly positive.
Double immunofluorescence staining
Skin sections were prepared for immunofluorescence stain-
ing as previously described (19). Briefly, five-micrometer cryo-
stat sections were incubated in methanol with 0.3% hydro-
gen peroxide, followed by blocking with 5% normal donkey
serum (Jackson ImmunoResearch Laboratories). They were
incubated overnight at 4℃with goat anti-human TLR3 poly-
clonal antibodies (1:50 in PBS, Santa Cruz Biotechnology).
Then, tissue sections were incubated with Alexa Fluor 488-
conjugated secondary antibodies (1:800 in PBS, Molecular
probes, Eugene, OR, U.S.A.) for 60 min. After three washes
in PBS, the tissue sections were blocked with 2.5% normal
horse serum (Vector Laboratories) and were then incubated
overnight at 4℃ with rabbit anti-human IFN- polyclonal
antibodies (1:50 in PBS, Santa Cruz Biotechnology). Subse-
quently, the tissue sections were incubated with biotin-con-
jugated secondary antibodies (1:200 in PBS, Jackson Immuno-
Research Laboratories) for 60 min and also with Streptavidin
Alexa Fluor 546 conjugate (1:1,000 in PBS, Molecular probes)
for 60 min. The immunolocalization of TLR3 and IFN- in
the skin was determined by Laser Scanning Confocal micros-
copy. The excitations of Alexa Fluor 488 and Alexa Fluor 546
were measured at laser wavelengths of 488 nm and 546 nm,
respectively.
RESULTS
TLR mRNA expression in normal human skin and VV
and MC skin lesions
We examined the expression of TLR2, 3, 4, 7, and 9 mRNA
in samples of normal human skin and in the VV and MC spec-
imens by RT-PCR (Fig. 1). TLR2, 4, and 7 mRNA was con-
stitutively expressed in normal (non-infected) human skin. Lit-
tle expression of TLR3 and 9 mRNA was detected in these
skin samples. Compared to NS, TLR3 and 9 mRNA was
markedly upregulated in the VV and MC skin specimens
when compared to  -actin mRNA expression for each exper-
imental condition (Fig. 1). In contrast, there were little quan-
titative differences in the mRNA levels of TLR2, 4, and 7
between the NS and the viral-infected skin samples.
TLR expression and immunolocalization in normal
human skin and VV and MC skin lesions
We next examined the epidermal localization of TLR2, 3,
4, 7, and 9 expression by immunohistochemical staining of
normal human skin and VV and MC skin specimens (Fig. 2).
Our results indicated that TLR2 was diffusely expressed
throughout the whole epidermis except the horny layer in
the NS. In MC skin samples TLR2 was most strongly express-
ed in the epidermal cells adjacent to the molluscum bodies
in the suprabasal layer of the epidermis, whereas TLR2 expres-
sion was primarily localized in the granular and horny epi-
dermal layer in the VV skin specimens. In contrast to TLR2,
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Fig. 1. Expression of Toll-like receptor (TLR) mRNA in normal skin
(NS), verruca vulgaris (VV), and molluscum contagiosum (MC) skin
lesions. RT-PCR products were amplified from NS, VV, and MC
using specific DNA oligo primers for the human TLR2, 3, 4, 7, and 9.
The mRNA expression was normalized with  -actin mRNA expres-
sion for each experimental condition (A). The level of mRNA expres-
sion for each of these gene products in NS, VV, and MC was pre-
sented by fold increases over that of NS (B). Each bar represents
mean±S.E.M.
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Fig. 2. Immunolocalization of Toll-like receptors (TLRs) in normal skin (NS), verruca vulgaris (VV), and molluscum contagiosum (MC) skin
lesions. TLRs were immunolocalized in NS, VV, and MC skin samples using specific anti-human TLR2, 3, 4, 7, and 9 polyclonal antibod-
ies. Original magnification,×100.
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NS VV MCTLR3 was barely detectable in the epidermis of NS; howev-
er, it was highly expressed in epidermal cells adjacent to the
molluscum bodies and also in the epidermal granular and
horny layer of the epidermis that express viral inclusion bod-
ies in the MC and VV skin samples. TLR4 was also expressed
in the epidermis of NS predominantly beneath the granular
layer and was more pronounced in epidermal cells adjacent
to the molluscum bodies in the MC specimens and localized
to the granular and horny layer in the VV specimens. In NS
samples TLR7 was found to be expressed in the epidermal
spinous and basal layer, but principally localized in the gran-
ular layer of the epidermis in cells containing viral inclusion
bodies. Finally, TLR9 was weakly expressed in the basal and
lower spinous layer of the epidermis in NS but strongly
expressed in the epidermal cells expressing viral particles.
Co-expression of TLR3 and antiviral proinflammatory
cytokines in VV and MC skin lesions
In addition to TLR, we also measured the expression of
IFN- and TNF- in normal human skin and in VV and
MC specimens by RT-PCR and immunohistochemical stain-
ing. These particular cytokines were selected for these studies
because they are believed to play an important role in host
responses to viral infections. Our results indicated that IFN-
and TNF- mRNA was upregulated in both the VV and MC
skin lesions compared to expression in NS (Fig. 3). Immuno-
histochemical studies indicated that both IFN- and TNF-
were highly expressed in epidermal cells adjacent to the
molluscum bodies in the MC skin specimens and strongly
expressed in the granular layer in the VV skin samples (Fig.
4A, B).
Next, the co-expression of IFN- and TLR3 in normal, VV,
and MC skin samples was examined by double-labeled im-
munofluorescence staining in three VV and MC infected
skin specimens. It was demonstrated that IFN- and TLR3
were principally co-expressed in the epidermal cells adjacent
to the molluscum bodies in the MC skin specimens as well
as in the epidermal granular and horny layers with viral inclu-
sion bodies in the VV skin samples. IFN- expression was
principally localized to the TLR3-positive epidermal cells.
Therefore, these results indicated that the expression of IFN-
was localized to the TLR3 expressing epidermal cells (Fig. 4C).
DISCUSSION
Our results in this study indicated that normal human skin
constitutively expresses TLR2, 4, and 7 mRNA but little
TLR3 and 9 mRNA. Likewise, the immunohistochemical
staining of NS revealed that TLR2, 4, and 7 were diffusely
expressed throughout the epidermis; however, TLR9 was
weakly expressed in the basal and lower spinous layers and
TLR3 was barely detected. Kawai et al. (13) previously report-
ed that both TLR2 and 4 were highly expressed in the basal
layer of normal human skin. In contrast, Pivarcsi et al. (20)
reported that TLR2 was principally expressed in the granu-
lar epidermal layer, whereas TLR4 was expressed in the basal
layer of the epidermis. Baker et al. (16) reported that TLR2
was strongly expressed in the whole epidermis of normal human
skin, but the expression of TLR3 and 4 was not detected. Kol-
lisch et al. (21) failed to detect TLR4, 7, and 9 mRNA expres-
sion in neonatal foreskin. Most recently, Lebre et al. (22) demon-
strated that normal keratinocytes constitutively express TLR
2, 3, and 4 mRNA, but not TLR7. This discrepancy with
other studies might be due to differences in the methodolog-
ical techniques or reagents used in this study (16). In addi-
tion, these results might be due to the difference in the biop-
sy site and skin specimens, or to the staining methods. On
the other hand, we demonstrated TLR7 expression in nor-
mal keratinocytes, which has never been reported in previous
studies. However, it is possible that there might be only a
nonspecific activation of normal keratinocytes by undefined
TLR7 ligands, endogenous or exogenous, which cannot be
explained by TLR7-mediated specific effects such as the TLR7-
imiquimod interaction.
VV and MC are caused by the double stranded DNA human
Expression of Toll-Like Receptors in Verruca and Molluscum Contagiosum 311
A
B
IFN-
TNF-
-actin
Size marker NS VV MC
R
e
l
a
t
i
v
e
 
f
o
l
d
 
i
n
c
r
e
a
s
e
40
25
10
0
IFN- TNF- mRNA
Fig. 3. IFN- and TNF- mRNA expression in normal skin (NS),
verruca vulgaris (VV), and molluscum contagiosum (MC) skin lesions.
RT-PCR products were amplified from normal skin (NS), VV, and
MC skin samples using primers specific DNA oligo primers for
IFN- ‚ and TNF- . The mRNA expression was normalized with  -
actin mRNA for each experimental condition (A). The level of mRNA
expression of VV and MC was presented by fold increases over
that of NS (B). Each bar represents mean ±S.E.M.
NS
VV
MCpapilloma virus and MC virus, respectively (23, 24). The pre-
cise mechanism of the human immune response to these viral
skin diseases remains unclear. Cutaneous viral infections have
been proposed to induce localized inflammatory and antiviral
responses that are believed to result in the resolution of viral
skin lesions (25, 26). Keratinocytes are one of the first cuta-
neous cell types to encounter various microbes including the
papilloma and molluscum viruses. Keratinocyte TLRs are
believed to play an important role in pathogen recognition
and host innate immune responses in the skin. In recent stud-
ies, TLR3, 7, and 9 were shown to recognize different kinds
of viruses (27, 28). In addition, imiquimod, a TLR7 agonist,
has been shown to be an effective drug for the treatment of
papilloma- induced warts (29). To our knowledge, however,
the expression patterns of the TLRs in common viral skin
diseases such as VV and MC are still unknown.
In this study, TLR3 mRNA was not detected in normal
human skin samples, but clearly expressed in VV and MC skin
specimens. Likewise, although low levels of TLR9 mRNA
were noted in normal human skin, this was also augmented
in VV and MC skin samples. Immunohistochemical staining
likewise demonstrated that TLR2, 4, and 7 were expressed
on the keratinocytes in the epidermis. Keratinocytes adjacent
to epidermal cells containing viral inclusion bodies also ex-
pressed TLR3 and 9. These results support the potential role
of these keratinocyte TLRs in the recognition and response to
cutaneous papilloma and molluscum virus infections. Further-
more, it was notable that although TLR3 expression was bare-
ly detected in the normal human skin, expression was clearly
augmented in the hyperkeratotic epidermis of the VV spec-
imens and in the vicinity of the molluscum bodies in the MC
skin lesions.
TLR3-activated cells have been reported to induce NF-
B activation, which results in the production of various proin-
flammatory cytokines including TNF- , interleukin-1 (IL-
1), and IL-8 (30). A second TLR3-activated signaling path-
way activates the type I-IFN promoter that induces the release
of antiviral cytokines such as IFN / (31-33). To examine the
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Fig. 4. Immunolocalization of IFN- and TNF- in normal skin (NS), verruca vulgaris (VV), and molluscum contagiosum (MC) skin lesions.
IFN- (A) and TNF- (B) were immunolocalized in NS, VV, and MC skin samples using specific anti-human IFN- and TNF- polyclonal
antibodies. IFN- (red) and TLR3 (green) co-localization studies in human NS, VV, and MC skin samples were examined in C. Original mag-
nification, ×100.
NS VV MC
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Cantiviral immune response through cutaneous TLR activa-
tion, we assessed IFN- and TNF- in normal and viral
infected skin samples. Our results indicated that IFN- and
TNF- mRNA were upregulated in the viral infected skin
lesions, as compared to normal skin. Furthermore, immuno-
histochemical staining indicated that the expression of IFN-
and TNF- was increased in the epidermal cells adjacent to
the molluscum bodies and also in the granular layer of the
VV specimens that contained many viral particles. The results
of double-labeled immunofluorescent analysis also indicated
that the expression of these proinflammatory cytokines was
co-localized in the epidermis in the same regions as TLR3
in VV and MC skin lesions.
Although activation of TLR9 as well as TLR3 can induce
production of type I IFNs (34), a recent report revealed that
double-stranded RNA viral reactivity in keratinocytes is impor-
tant for subsequent IFN- -mediated immune reactions (35),
and that vaccinia virus (dsDNA virus) belonging to the Poxviri-
dae family-like molluscum virus inhibited multiple TLR path-
ways, including TLR3 (36). Thus, we used a TLR3 antibody
rather than a TLR9 antibody along with IFN- and TNF-
for double immunofluorescence staining in this study.
In summary, our studies indicated that epidermal TLR3 and
9 may have an important role in cutaneous innate immune
responses to commonly encountered cutaneous viral infections
such as VV and MC. Understanding the relationship between
viral skin infections and epidermal TLR responses may permit
novel insights into cutaneous immune responses and the devel-
opment of new anti-viral therapeutic agents.
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